Dexmedetomidine (Precedex®) for Severe Alcohol Withdrawal Syndrome (AWS) and Alcohol Withdrawal Delirium (AWD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2014 by Denver Health and Hospital Authority
Sponsor:
Information provided by (Responsible Party):
Ivor Douglas, Denver Health and Hospital Authority
ClinicalTrials.gov Identifier:
NCT01362205
First received: May 24, 2010
Last updated: June 9, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2015
  Estimated Primary Completion Date: March 2015 (Final data collection date for primary outcome measure)